Global Ophthalmology Drugs Market Study 2015-2025, by Segment (Lucentis (ranibizumab), Eylea (aflibercept), Avastin (bevacizumab)), by Market (Chorioretinitis, Choroiditis, Retinitis), by Company (Novartis, Regeneron, Roche)

November 2018 | 47 pages | ID: GCA47FAC86CEN
99Strategy

Abstracts

Snapshot

The global Ophthalmology Drugs market will reach xxx Million USD in 2018 and with a CAGR if xx% between 2019-2025.

Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):

• Lucentis (ranibizumab)
• Eylea (aflibercept)
• Avastin (bevacizumab)
• Restasis (cyclosporine)
• Alphagan (brimonidine tartrate)
• Lumigan (bimatoprost)
• Xalatan (latanoprost

Demand Coverage (Market Size & Forecast, Consumer Distribution):

• Chorioretinitis
• Choroiditis
• Retinitis
• Others

Company Coverage (Sales data, Main Products & Services etc.):

• Novartis
• Regeneron
• Roche
• Bayer
• Allergan
• Shire
• Mallinckrodt

Major Region Market

• North America
• Europe
• Asia-Pacific
• South America
• Middle East & Africa

Contents

1 INDUSTRY OVERVIEW

1.1 Ophthalmology Drugs Industry
  1.1.1 Overview
  1.1.2 Products of Major Companies
1.2 Market Segment
  1.2.1 Industry Chain
  1.2.2 Consumer Distribution
1.3 Price & Cost Overview

2 OPHTHALMOLOGY DRUGS MARKET BY TYPE

2.1 By Type
  2.1.1 Lucentis (ranibizumab)
  2.1.2 Eylea (aflibercept)
  2.1.3 Avastin (bevacizumab)
  2.1.4 Restasis (cyclosporine)
  2.1.5 Alphagan (brimonidine tartrate)
  2.1.6 Lumigan (bimatoprost)
  2.1.7 Xalatan (latanoprost
2.2 Market Size by Type
2.3 Market Forecast by Type

3 GLOBAL MARKET DEMAND

3.1 Segment Overview
  3.1.1 Chorioretinitis
  3.1.2 Choroiditis
  3.1.3 Retinitis
  3.1.4 Others
3.2 Market Size by Demand
3.3 Market Forecast by Demand

4 MAJOR REGION MARKET

4.1 Global Market Overview
  4.1.1 Market Size & Growth
  4.1.2 Market Forecast
4.2 Major Region
  4.2.1 Market Size & Growth
  4.2.2 Market Forecast

5 MAJOR COMPANIES LIST

5.1 Novartis (Company Profile, Sales Data etc.)
5.2 Regeneron (Company Profile, Sales Data etc.)
5.3 Roche (Company Profile, Sales Data etc.)
5.4 Bayer (Company Profile, Sales Data etc.)
5.5 Allergan (Company Profile, Sales Data etc.)
5.6 Shire (Company Profile, Sales Data etc.)
5.7 Mallinckrodt (Company Profile, Sales Data etc.)

6 CONCLUSION

List Of Tables

LIST OF TABLES

Table GLOBAL OPHTHALMOLOGY DRUGS MARKET 2015-2018, BY TYPE, IN USD MILLION
Table Global Ophthalmology Drugs Market 2015-2018, by Type, in Volume
Table Global Ophthalmology Drugs Market Forecast 2019-2025, by Type, in USD Million
Table Global Ophthalmology Drugs Market Forecast 2019-2025, by Type, in Volume
Table Novartis Overview List
Table Ophthalmology Drugs Business Operation of Novartis (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Regeneron Overview List
Table Ophthalmology Drugs Business Operation of Regeneron (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Roche Overview List
Table Ophthalmology Drugs Business Operation of Roche (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Bayer Overview List
Table Ophthalmology Drugs Business Operation of Bayer (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Allergan Overview List
Table Ophthalmology Drugs Business Operation of Allergan (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Shire Overview List
Table Ophthalmology Drugs Business Operation of Shire (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Mallinckrodt Overview List
Table Ophthalmology Drugs Business Operation of Mallinckrodt (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

List Of Figures

LIST OF FIGURES

Figure Global Ophthalmology Drugs Market Growth 2015-2018, by Type, in USD Million
Figure Global Ophthalmology Drugs Market Growth 2015-2018, by Type, in Volume